CNL and aCML should be considered as a single entity based on molecular profiles and outcomesGonzalo Carreño‐Tarragona, Nicholas C.P. Cross, Teresa González‐Martínez et al.|Blood Advances|2023Cited by 32
Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational statusLourdes Florensa, Leonor Arenillas, A Domingo et al.|International Journal of Hematology|2008Cited by 25
Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of MyelofibrosisIrene Pastor‐Galán, Francisco Cervantes, Juan Carlos Hernández‐Boluda et al.|Medicina Clínica (English Edition)|2020Cited by 12
Características clínico-biológicas de los pacientes con mielofibrosis: un análisis de 1.000 casos del Registro Español de MielofibrosisIrene Pastor‐Galán, Francisco Cervantes, Juan Carlos Hernández‐Boluda et al.|Medicina Clínica|2020Cited by 5
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemiaGonzalo Carreño‐Tarragona, On behalf of the MPN Spanish Group (GEMFIN), Rodrigo Gil-Manso et al.|Leukemia|2026Cited by 0